NASDAQ:IOBT
Delisted

Io Biotech Stock Insider Trading

etoro logo Buy IOBT
*Your capital is at risk
$0.0480
+0 (+0%)
At Close: Jul 08, 2026

IO Biotech Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 93.25M and sold 2.79M IOBT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 93.25M shares
Sell 2.79M shares
92% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Smith David V
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Hunter Heidi
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Hirth Peter
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Glaub Kathleen Sereda
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Elling Christian E
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Collins Helen Louise
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Collins Helen Louise
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Elling Christian E
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Glaub Kathleen Sereda
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Hirth Peter
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Hunter Heidi
Director
Director 35 144
Value: $52.7K
Jun 05, 2025
Buy
Stock Option (Right to Buy)
A-Award
Smith David V
Director
Director 35 144
Value: $52.7K
May 30, 2025
Buy
Common Stock
P-Purchase
Hunter Heidi
Director
Director 15 000
Value: $20.9K
May 30, 2025
Buy
Common Stock
P-Purchase
Hunter Heidi
Director
Director 15 000
Value: $20.9K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Zocca Mai-britt
Chief Executive Officer
CEO / President 580 000
Value: $620.6K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Sullivan Amy
Chief Financial Officer
C-Suite Officer 215 000
Value: $230.1K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Smith Devin Whittemore
General Counsel
Officer 140 000
Value: $149.8K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Burkavage Brian
Chief Accounting Officer
Officer 65 000
Value: $69.6K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Ahmad Qasim Iftikhar
Chief Medical Officer
Officer 215 000
Value: $230.1K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Ahmad Qasim Iftikhar
Chief Medical Officer
Officer 215 000
Value: $230.1K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Burkavage Brian
Chief Accounting Officer
Officer 65 000
Value: $69.6K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Smith Devin Whittemore
General Counsel
Officer 140 000
Value: $149.8K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Sullivan Amy
Chief Financial Officer
C-Suite Officer 215 000
Value: $230.1K
Apr 02, 2025
Buy
Stock Option (Right to Buy)
A-Award
Zocca Mai-britt
Chief Executive Officer
CEO / President 580 000
Value: $620.6K
Dec 23, 2024
Buy
Common Stock
P-Purchase
Ahmad Qasim Iftikhar
Chief Medical Officer
Officer 31 350
Value: $26.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IO BIOTECH, INC.
IO Biotech
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and ne...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE